NM_000249.4:c.1905C>T
Variant names: 
Variant summary
Our verdict is Likely benign. The variant received -3 ACMG points: 2P and 5B. PM2BP4_ModerateBP6_ModerateBP7
The NM_000249.4(MLH1):c.1905C>T(p.Asn635Asn) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
 Genomes: not found (cov: 31) 
Consequence
 MLH1
NM_000249.4 synonymous
NM_000249.4 synonymous
Scores
 2
Clinical Significance
Conservation
 PhyloP100:  2.99  
Publications
6 publications found 
Genes affected
 MLH1  (HGNC:7127):  (mutL homolog 1) The protein encoded by this gene can heterodimerize with mismatch repair endonuclease PMS2 to form MutL alpha, part of the DNA mismatch repair system. When MutL alpha is bound by MutS beta and some accessory proteins, the PMS2 subunit of MutL alpha introduces a single-strand break near DNA mismatches, providing an entry point for exonuclease degradation. The encoded protein is also involved in DNA damage signaling and can heterodimerize with DNA mismatch repair protein MLH3 to form MutL gamma, which is involved in meiosis. This gene was identified as a locus frequently mutated in hereditary nonpolyposis colon cancer (HNPCC). [provided by RefSeq, Aug 2017] 
MLH1 Gene-Disease associations (from GenCC):
- Lynch syndromeInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: G2P, ClinGen, Orphanet
 - Lynch syndrome 2Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Genomics England PanelApp
 - Muir-Torre syndromeInheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Genomics England PanelApp, Ambry Genetics, G2P, Orphanet
 - mismatch repair cancer syndrome 1Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae), Orphanet, ClinGen
 - Lynch syndrome 1Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
 - ovarian cancerInheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
 - malignant pancreatic neoplasmInheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
 - rhabdomyosarcomaInheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
 - prostate cancerInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
 - breast cancerInheritance: AD Classification: NO_KNOWN Submitted by: Ambry Genetics
 - hereditary breast carcinomaInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
 
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Likely_benign. The variant received -3 ACMG points.
PM2
Very rare variant in population databases, with high coverage; 
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.45). 
BP6
Variant 3-37048525-C-T is Benign according to our data. Variant chr3-37048525-C-T is described in ClinVar as Likely_benign. ClinVar VariationId is 924663.Status of the report is criteria_provided_single_submitter, 1 stars. 
BP7
Synonymous conserved (PhyloP=2.99 with no splicing effect.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes  Cov.: 31 
GnomAD3 genomes 
Cov.: 
31
GnomAD4 exome Cov.: 31 
GnomAD4 exome 
Cov.: 
31
GnomAD4 genome  Cov.: 31 
GnomAD4 genome 
Cov.: 
31
ClinVar
Significance: Likely benign 
Submissions summary: Benign:1 
Revision: criteria provided, single submitter
LINK: link 
Submissions by phenotype
Hereditary cancer-predisposing syndrome    Benign:1 
May 07, 2019
Color Diagnostics, LLC DBA Color Health
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.